Cargando…
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
INTRODUCTION: Improving technologies for the detection and purification of bone marrow (BM) micrometastatic cells in breast cancer patients should lead to earlier prognosis of the risk of relapse and should make it possible to design more appropriate therapies. The technique used has to overcome the...
Autores principales: | Choesmel, Valérie, Pierga, Jean-Yves, Nos, Claude, Vincent-Salomon, Anne, Sigal-Zafrani, Brigitte, Thiery, Jean-Paul, Blin, Nathalie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549166/ https://www.ncbi.nlm.nih.gov/pubmed/15318937 http://dx.doi.org/10.1186/bcr898 |
Ejemplares similares
-
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
por: Vincent-Salomon, A, et al.
Publicado: (2007) -
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
por: Pierga, J-Y, et al.
Publicado: (2003) -
Bone marrow micrometastases in early breast cancer–30-year outcome
por: Mansi, J, et al.
Publicado: (2016) -
Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004) -
Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)